These innovative therapies , Semaglutide , represent a significant advancement in managing type 2 diabetes and possibly associated conditions . These drugs are categorized as GLP-1 hormone agonists , signifying they function to emulate the endogenous GLP-1 peptide, enhancing glucose release and s